NICM
ADPT icon

Neo Ivy Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Neo Ivy Capital Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-153,826
Closed -$2.5M – 320
2025
Q4 		$2.5M Buy
+153,826
New +$2.51M 0.39% 103
2022
Q1 		– Sell
-712
Closed -$20K – 469
2021
Q4 		$20K Buy
712
+203
+40% +$6.22K 0.03% 357
2021
Q3 		$25K Buy
509
+316
+164% +$11.4K 0.03% 377
2021
Q2 		$8K Buy
193
+141
+271% +$5.48K 0.01% 398
2021
Q1 		$2K Sell
52
-123
-70% -$6.66K ﹤0.01% 451
2020
Q4 		$10K Sell
175
-4,167
-96% -$215K 0.01% 380
2020
Q3 		$211K Buy
4,342
+3,833
+753% +$161K 0.21% 188
2020
Q2 		$25K Sell
509
-1,628
-76% -$59.4K 0.03% 377
2020
Q1 		$59K Buy
+2,137
New +$59.6K 0.1% 288

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return